Loading clinical trials...

A Phase 2 Study of OPC-262 in Patients With Type 2 Diabetes | Clinical Trials | Clareo Health

COMPLETEDPhase 2NCT00857558

A Phase 2 Study of OPC-262 in Patients With Type 2 Diabetes

A multicenter, randomized, double-blind, placebo-controlled, group-comparison study to investigate the safety and efficacy of OPC-262 in patients with type 2 diabetes

Lead sponsor: Kyowa Kirin Co., Ltd.•8 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

COMPLETEDNA

iDecide.Decido: Diabetes Medication Decision Support Study

NCT01427660 · Diabetes, Type 2

COMPLETEDPhase 3

A Phase 3 Study of OPC-262 in Patients With Type 2 Diabetes

NCT01193179 · Diabetes, Type 2

COMPLETEDPhase 3

A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control

NCT00246987 · Diabetes, Type 2

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 9, 2017Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment350

Start dateJan 2009

Last updatedMar 9, 2017

Condition

Diabetes, Type 2

Locations shown

Chubu Regin

Chugoku Region

Hokkaido Region

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 9, 2017Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions